NICE Technology Appraisal 875 (TA875) recommends semaglutide for managing weight in adults with obesity within specialist weight management services, typically for people with a BMI 35 kg/m with a weight-related comorbidity, or 30-34.9 kg/m in certain circumstances
10.1105/tpc.10.8.1391 Plant Cell 43 LivakK
A GP explains what to watch out for Injectable medications originally developed for the treatment of diabetes are also effective for weight loss, and have surged in popularity for this purpose around the world
Ro aims to help millions of Americans living with obesity achieve their weight loss goals through access to prescription treatment supported by personalized provider care, diagnostic testing with at-home sample collection, and 1:1 coaching from nurses
Patients who come in with one concern often stay because we treat their skin like a long-term relationship, not a single transaction
Less than 100 mg/dL (5.6 mmol/L) is considered normal